Form 4 Tracker
Mark A Goldsmith

Director, President and Chief Executive Officer · 7 filings · Latest: Sep 16, 2026

Revolution Medicines, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RVMD
GOLDSMITH MARK A—Dec 15, 2025
Proposed Sale
$77.8114,964$1.2M—
RVMD
J H GOLDSMITH & M A GOLDSMITHCO-TTEE JONATHAN GOLDSMITH REV TRU/A/D 8/16/2023—Nov 25, 2025
Proposed Sale
$73.663,000$221.0K—
RVMD
THE REBECCA GOLDSMITH REVOCABLE TRUST—Nov 25, 2025
Proposed Sale
$73.663,000$221.0K—
RVMD
MARK A GOLDSMITH—Nov 25, 2025
Proposed Sale
$73.6660,000$4.4M—
RVMD
MARK A GOLDSMITH—Nov 18, 2025
Proposed Sale
$69.1420,000$1.4M—
RVMD
MARK A GOLDSMITH—Nov 12, 2025
Proposed Sale
$64.0820,000$1.3M—
RVMD
MARK A GOLDSMITH—Nov 7, 2025
Proposed Sale
$61.3830,000$1.8M—
RVMD
MARK A GOLDSMITH—Oct 17, 2025
Proposed Sale
$49.6810,000$496.8K—
RVMD
MARK A GOLDSMITH—Oct 16, 2025
Proposed Sale
$49.5610,000$495.6K—
RVMD
GOLDSMITH MARK A—Sep 15, 2025
Proposed Sale
$46.5513,236$616.1K—
RVMD
GOLDSMITH MARK A—Jun 16, 2025
Proposed Sale
$40.7913,235$539.9K—
RVMD
GOLDSMITH MARK A—Mar 17, 2025
Proposed Sale
$38.8911,890$462.4K—
RVMD
GOLDSMITH MARK A—Dec 16, 2024
Proposed Sale
$44.9311,561$519.4K—
RVMD
REBECCA EVE GOLDSMITH TR U/A DTD 12/15/2011—Nov 1, 2024
Proposed Sale
$53.505,000$267.5K—
RVMD
J H GOLDSMITH & M A GOLDSMITH CO-TTEE JONATHAN GOLDSMITH REV TRU/A/D 8/16/2023—Nov 1, 2024
Proposed Sale
$53.505,000$267.5K—
RVMD
MARK A GOLDSMITH—Nov 1, 2024
Proposed Sale
$53.5060,000$3.2M—
RVMD
MARK A GOLDSMITH—Oct 11, 2024
Proposed Sale
$49.5030,000$1.5M—
RVMD
MARK A GOLDSMITH—Oct 1, 2024
Proposed Sale
$45.3510,000$453.5K—
RVMD
GOLDSMITH MARK A—Sep 16, 2024
Proposed Sale
$42.1211,561$486.9K—

← Previous

Page 2 of 2